• AS ONE started FY3/26 on a profitable note – AS ONE's Q1 results demonstrate strong profitability driven by significant margin expansion and disciplined cost management, which allowed the company to deliver robust earnings growth despite top-line results being tempered by macro factors and falling slightly short of ambitious internal targets. The company's new detailed disclosure on its small but high-growth Services business highlights a key pillar of its medium-term plan and a potential catalyst for margin accretion and further accelerate growth. We think if e-commerce sales met internal targets and weakness in the Medical segment is addressed, AS ONE would be on track to exceed its FY3/26 targets.

07 Aug 2025
AS ONE (7476) Q1 FY3/26 results update: Margin expansion drove a profitable start to FY3/26
MEDIPAL HOLDINGS Corporation (7459:TKS), 0 | Ship Healthcare Holdings, Inc. (3360:TKS), 0 | Suzuken Co., Ltd. (9987:TKS), 0 | TOHO HOLDINGS CO., LTD. (8129:TKS), 0 | Ci Medical Co., Ltd. (3540:TKS), 0 | Medius Holdings Co., Ltd. (3154:TKS), 0 | MonotaRO Co., Ltd. (3064:TKS), 0 | ASKUL Corporation (2678:TKS), 0 | Trusco Nakayama Corporation (9830:TKS), 0 | Thermo Fisher Scientific (TMO:NYSE), 0 | Avantor Inc (AVTR:NYSE), 0 | Sartorius AG (SRT:ETR), 0 | Bruker Corporation (BRKR:NAS), 0 | Bunzl plc (BNZL:LON), 2,285 | W W Grainger (GWW:NYSE), 0 | MSC Industrial Direct Co (MSM:NYSE), 0 | Genuine Parts Company (GPC:NYSE), 0 | CDW Corporation (CDW:NAS), 0

Sign up for free to access
Get access to the latest equity research in real-time from 12 commissioned providers.
Get access to the latest equity research in real-time from 12 commissioned providers.
AS ONE (7476) Q1 FY3/26 results update: Margin expansion drove a profitable start to FY3/26
MEDIPAL HOLDINGS Corporation (7459:TKS), 0 | Ship Healthcare Holdings, Inc. (3360:TKS), 0 | Suzuken Co., Ltd. (9987:TKS), 0 | TOHO HOLDINGS CO., LTD. (8129:TKS), 0 | Ci Medical Co., Ltd. (3540:TKS), 0 | Medius Holdings Co., Ltd. (3154:TKS), 0 | MonotaRO Co., Ltd. (3064:TKS), 0 | ASKUL Corporation (2678:TKS), 0 | Trusco Nakayama Corporation (9830:TKS), 0 | Thermo Fisher Scientific (TMO:NYSE), 0 | Avantor Inc (AVTR:NYSE), 0 | Sartorius AG (SRT:ETR), 0 | Bruker Corporation (BRKR:NAS), 0 | Bunzl plc (BNZL:LON), 2,285 | W W Grainger (GWW:NYSE), 0 | MSC Industrial Direct Co (MSM:NYSE), 0 | Genuine Parts Company (GPC:NYSE), 0 | CDW Corporation (CDW:NAS), 0
- Published:
07 Aug 2025 - Author:
-
Pages:
11 -
• AS ONE started FY3/26 on a profitable note – AS ONE's Q1 results demonstrate strong profitability driven by significant margin expansion and disciplined cost management, which allowed the company to deliver robust earnings growth despite top-line results being tempered by macro factors and falling slightly short of ambitious internal targets. The company's new detailed disclosure on its small but high-growth Services business highlights a key pillar of its medium-term plan and a potential catalyst for margin accretion and further accelerate growth. We think if e-commerce sales met internal targets and weakness in the Medical segment is addressed, AS ONE would be on track to exceed its FY3/26 targets.